Multidisciplinary Treatment for Squamous Cell Carcinoma of the Anal Canal

Hideaki Karasawa, Shinobu Ohnuma, Kazuhiro Watanabe, Takahiro Tsuchiya, Hirofumi Imoto, Takeshi Aoki, Katsuyoshi Kudoh, Naoki Tanaka, Munenori Nagao, Tomoya Abe, Hiroaki Musha, Fuyuhiko Motoi, Takashi Kamei, Takeshi Naito, Michiaki Unno

Research output: Contribution to journalArticlepeer-review


Chemoradiotherapy(CRT)has been recognized as a standard treatment for locoregional squamous cell carcinoma of the anal canal in Western countries. However, surgery had historically been considered as a standard treatment and there are only a few reports on CRT for anal canal cancer in Japan. In this study, we analyzed medical records of 5 anal canal cancer patients treated with CRT in our hospital between 2005 and 2015. Patients' characteristics were as follows: median age, 70 years (range 42-80 years); male/female, 1/4; and clinical Stage I / III a/ III b, 3/1/1. The regimens of chemotherapy were MMC plus 5-FU in 4 patients and CDDP in 1 patient. The median follow-up period was 30 months(range, 6 to 100 months). After CRT, 4 patients achieved complete response. The other patient with partial response underwent salvage surgery. All patients were alive without recurrence. In conclusion, our retrospective study showed that CRT is considered to be a standard treat- ment for anal canal cancer.

Original languageEnglish
Pages (from-to)2009-2010
Number of pages2
JournalGan to kagaku ryoho. Cancer & chemotherapy
Issue number12
Publication statusPublished - 2017 Nov 1

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Multidisciplinary Treatment for Squamous Cell Carcinoma of the Anal Canal'. Together they form a unique fingerprint.

Cite this